Slingshot members are tracking this event:
Moleculin (MBRX) Announces Interim Results in Pediatric Brain Tumor Phase 1 Clinical Trial
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Oct 01, 2020
Don’t see a project related to the catalyst you care about?
Related Keywords Pediatric Brain Tumor, Phase 1 Data